PRQR icon

ProQR Therapeutics
PRQR

Overview Fund Trends Analyst Outlook Journalist POV

55 hedge funds and large institutions have $47.5M invested in ProQR Therapeutics in 2023 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 18 increasing their positions, 4 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more ownership

Funds ownership: →

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

21% less capital invested

Capital invested by funds: $60M → $47.5M (-$12.4M)

26% less call options, than puts

Call options by funds: $705K | Put options by funds: $950K

Holders
55
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$705K
Puts
$950K
Net Calls
Net Calls Change

Top Buyers

1
+$6.18M
2
+$2.39M
3
+$2M
4
Morgan Stanley
Morgan Stanley
New York
+$576K
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
+$470K

Top Sellers

1
-$1.72M
2
-$617K
3
-$610K
4
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$381K
5
GGHC
Gilder Gagnon Howe & Co
New York
-$359K
Name Holding Trade Value Shares
Change 		Change in
Stake
51
$2.13K
52
$1.08K
53
$426
54
$426
55
–
56
–
57
–
58
–
59
–
60
–
61
–
62
–
1 2
3